Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13030402
Abstract: Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated with poorer patient outcomes. It is considered a potential therapeutic target in breast cancer, even though the full spectrum… read more here.
Keywords: growth; breast tumour; ptk6; kinase ... See more keywords
Putting the BRK on breast cancer: From molecular target to therapeutics
Sign Up to like & getrecommendations! Published in 2021 at "Theranostics"
DOI: 10.7150/thno.49716
Abstract: BReast tumor Kinase (BRK, also known as PTK6) is a non-receptor tyrosine kinase that is highly expressed in breast carcinomas while having low expression in the normal mammary gland, which hints at the oncogenic nature… read more here.
Keywords: brk breast; breast; brk; breast cancer ... See more keywords